Discharge From Treatment for Drug Use

It must be emphasized that methadone maintenance treatment is a

medical treatment for narcotic addiction. Recent research has

found that abstinent former heroin users have irregularities

within their immune and endocrine systems. However, these

irregularities are normalized with methadone maintenance. This further

underscores that methadone maintenance is a medical treatment

for a medical condition that has sociological and psychological

aspects, as do many medical conditions, ie heart disease. No

other treatment for opiate addiction as is successful as

methadone maintenance, resulting in a 92% reduction in heroin use when treatment is

appropriately done. No other treatment

for heroin addiction can boast such a success rate, and in fact

very few other medical treatments have as high a success rate as

methadone maintenance.

Programs who have high rates of illicit opioid use are, put

simply, “not providing proper treatment.” Discharging patients

for heroin use is unethical and usually programs which use such

tactics are not providing adequate dosage or are using the

medication as a tool to manipulate the patient’s behavior. Such

procedures would be considered unethical in every other realm of

medicine, but because drug use has been perceived as a

behavioral problem, discharging patients for drug use has been

tolerated in methadone treatment.

Imagine how this feels to the patient in treatment. What if you

were diagnosed with cancer and went for the usual radiation

treatments. You followed everything the doctor told you to do,

but in the end the cancer was still growing. Now apply this to

methadone treatment: you would be discharged because you did

not respond to treatment. If you had cancer would you not want

the doctor to try something else, like chemotherapy and if that

failed perhaps some new experimental treatment? You would want

the doctor to try everything to save your life. The same is

true for the methadone patient, if 70 mg doesn’t work, then

perhaps 80 or 90 or 200 mg will work. For the cancer patient

perhaps two radiation treatments will work. But imagine the

doctor blaming the cancer patient for not responding to

treatment and then discharging them. “If only you had tried

harder!” This happens to methadone patients every day, they are

blamed for the failures of their programs.

Not only does discharging methadone patients from treatment do a

terrible disservice to the patient, but also to the community.

Think of the repercussions when a patient is discharged. It is

inevitable that they will relapse within a short time and

considering the threat of HIV, strain resistant TB, hepatitis

and endocarditis the effects that the discharge will have on the

family of the patient is tremendous. The patient will no longer

be able to support their family because they will be thrown into

a state of “drug craving.” The crime that one patient will have

to commit to maintain their drug use has been estimated to cost society from

$150,000 to over $300,000 a year. And if this former patient is

arrested, which is very likely, then they will be a ward of the

state costing between $30,000 to $60,000 a year. And should

this former patient become infected with HIV the cost can be as

high as $300,000 a year, and as people with AIDS are living

longer the costs are rising dramatically.

Now I ask you, which is better for the person, the community and

the state? A methadone patient receiving adequate treatment who

supports their family, pays their taxes, pays for their

treatment and is a productive member of the community, or a heroin addict who will cost the

community money that

could well be spent on better purposes?


A Comment on Discharging Patients for Using Cocaine

Many programs have adopted the policy of discharging methadone

patients for using cocaine. Presently there is no treatment for

cocaine use, except hospitalization and counseling and hoping

that this time something works. However, NAMA believes that it

is unethical to discharge patients and thus refuse to them

treatment for their heroin addiction because they have developed

an ancillary problem. In normal medical practice a patient with

diabetes who did not follow medical advise now developed heart

disease because of this would not be refused their insulin.

Neither should a medication that works for heroin addiction be

refused because of another drug problem.

There are programs that discharge for marijuana use. This

simply does not make sense nor does it serve the community or

the patient and their family. Marijuana is used by a

large number of Americans and is associated with neither the high crime rates nor the

significant medical consequences resultant from abuse of other illicit drugs or alcohol. Furthermore,

many AIDS patients use marijuana on medical advice as a means of countering the “wasting syndrome”.

Discharging methadone patients for using

marijuana results in an untreated heroin addict that will cost

the community in crime and money.

Similar Posts

  • The Pharmacology of Opioids

    Admin 04/18/2023

    Basic Pharmacology:  How Methadone Works Part 2 Basic Opioid Pharmacology All natural and synthetic opioids exhibit a three dimensional T-shaped configuration (Barchas, Berger, Ciaranello and Elliott, 1977). This T-shaped molecule has two broad hydrophobic surfaces which are at right angles and a methylated nitrogen which is usually charged at physiological pH. The charged nitrogen is…

  • Hot Topic Roundtable

    Admin 04/19/2023

    National Methadone Conference AMTA 2001 Tuesday, October 9th 2 P.M. Administrative Detox: Necessary Use or Abuse Joe Neuberger, Delaware NAMA James DePasquale, Long Beach Patient Committee This roundtable examined the practice of “administrative detoxification” from programs, and explored the conflicts between what programs often perceive as a necessary evil and patients often perceive as a…

  • AMTA Conference Comittee

    Admin 06/15/2023

    Conference 2000 American Methadone Treatment Association April 9-12, 2000 San Francisco Committee Chair John Finger Committee Members Assistant to the Chair, Michael Garrett Co-chair, Alice Diorio Committee James DePasquale Becky Duarte Barbara Finger Carlos Franco Greg Keller Howard Lotsof Judith Ostergard Carmen Pearman Diane Seaman Joycelyn Woods NAMA Events and Activities Exhibition Booth Booth Manager:…

  • We Remember

    Admin 09/17/2022

    Hector Valentin Maldonado February 14, 1942 – August 14, 2003 Acting President, 1996 – 1998 Acting Treasurer, 1995 – 1996 Vice President, 1989 – 1996 Hector Maldonado was a founding member of NAMA. He was a member of the committee during the first year that met when patients and professionals discussed the need to start…

  • NAMA IS REORGANIZING

    Admin 12/03/2022

    THE NATIONAL ALLIANCE OF METHADONE ADVOCATES, NAMA IS CURRENTLY UNDERGOING A PERIOD OF ADMINISTRATIVE REORGANIZATION, WHICH SHOULD BE COMPLETED SOON.  WE ASK YOUR COOPERATION IN HELPING FACILITATE THIS TRANSITION BY POSTPONING ALL NON-ESSENTIAL, NON-EMERGENCY COMMUNICATION.    THE WEBSITE (https://www.Methadone.org) AND THE PHONE LINE (212-595-6262) WILL CONTINUE TO OPERATE.  HOWEVER, UNTIL THE REORGANIZATION IS COMPLETE, WE…

  • Managed Care Resource Guide

    Admin 07/11/2021

    Education Series Number 7 August 2003 (Revised) What is Managed Care? Managed care is a complex system that involves the active coordination of, and the arrangement for, the provision of health services and coverage of health benefits. The most common types of Managed Care Organizations (MCOs) include Health Maintenance Organizations (HMOs), Preferred Provider Organizations (PPOs)…